Annual report pursuant to Section 13 and 15(d)

Segment Information (Tables)

v3.10.0.1
Segment Information (Tables)
12 Months Ended
Dec. 31, 2017
Segment Reporting [Abstract]  
Schedule of Revenue by Different Product Lines

The total revenue by different product lines was as follows:

 

    Years ended  
    December 31,  
Product Line   2017     2016  
    (restated)        
MicroParticle Catalyzed Biosensor (“MPC”)   $ 381,228     $ 282,516  
Particle ImmunoFiltration Assay (“PIFA”)     2,232,684       2,577,148  
Rapid Enzymatic Assay ("REA")     133,848       -  
Other     556,952       97,498  
Product Revenue Total   $ 3,304,712     $ 2,957,162  
License Fees     50,000       3,750  
Total Revenue   $ 3,354,712     $ 2,960,912  

Schedule of Revenue by Geographic Area Determined Based on Location of Customers

The total revenue by geographic area determined based on the location of the customers was as follows:

 

    Years ended  
    December 31,  
Geographic Region   2017     2016  
    (restated)        
United States   $ 2,679,549     $ 2,330,723  
People's Republic of China     502,131       502,998  
Rest of World     173,032       127,191  
Total Revenue   $ 3,354,712     $ 2,960,912